Cervical Polyps — Cost, Top Hospitals & Success Rates | MyMedicPlus

Cervical polyps are benign, soft, pedunculated growths arising from the mucous membrane of the endocervical canal (the channel running through the cervix connecting the uterine cavity to the vagina) or, less commonly, from the ectocervix (outer surface of the cervix). They range in size from a few millimetres to several centimetres and vary in colour from red-pink to purple-grey depending on their vascularity. The vast majority are benign inflammatory or hyperplastic proliferations of endocervical glandular tissue; malignant transformation is rare, occurring in approximately 0.5–1% of cervical polyps, and is more likely in large, irregular polyps in postmenopausal women.

Cervical polyps are diagnosed during routine pelvic examination when the polyp is visible at or through the external cervical os (opening). They are common — found in approximately 2–4% of all gynaecological examinations — and typically affect women between 40 and 60 years, often in the perimenopause or postmenopause. Many are entirely asymptomatic and discovered incidentally. When symptomatic, they cause intermenstrual bleeding, post-coital bleeding, abnormal vaginal discharge, or menorrhagia.

Treatment is by polypectomy — removal of the polyp — which can be performed as a simple outpatient office procedure without anaesthesia for small pedunculated polyps, or as a minor operative procedure for larger or sessile polyps. All removed polyps should be submitted for histological examination to exclude the rare malignancy. Because cervical polyps arise in the context of oestrogenic stimulation and endocervical inflammation, exclusion of concurrent endometrial pathology (endometrial polyps, hyperplasia, or carcinoma) is indicated in postmenopausal women presenting with any abnormal uterine bleeding.

Cervical polyps are the primary diagnosis. They are almost always benign; the histological types include inflammatory fibrous polyps, adenomatous hyperplastic polyps, and endometrial polyps that prolapse through the cervix. While malignant transformation is rare (below 1%), the small but real risk of malignancy justifies histological examination of all removed polyps. Additionally, cervical polyps may coexist with other cervical and uterine pathology that must be excluded: cervical intraepithelial neoplasia (CIN), endocervical adenocarcinoma in situ, endometrial polyps, endometrial hyperplasia, and endometrial carcinoma — particularly in postmenopausal women with abnormal bleeding.

Cervical ectropion (eversion of the endocervical glandular epithelium onto the ectocervix) may coexist with polyp formation and cause similar symptoms. Endometrial polyps — soft intrauterine growths arising from the endometrium — can prolapse through the cervix and be clinically indistinguishable from endocervical polyps on external examination, requiring hysteroscopy or transvaginal ultrasound for accurate distinction and treatment.

All patients with a visible cervical polyp are candidates for polypectomy, whether symptomatic or asymptomatic, to obtain histology and eliminate the polyp as a source of abnormal bleeding or infection risk. Polypectomy is a minor procedure with minimal risk, making it appropriate for essentially all patients including the elderly, pregnant women (with appropriate caution to avoid disrupting the pregnancy), and those with medical comorbidities. Pregnancy-related cervical polyps are typically managed expectantly until post-delivery unless bleeding is significant, as polypectomy during pregnancy carries a small risk of bleeding and cervical trauma.

Women with postmenopausal bleeding and a cervical polyp require additional investigation beyond simple polypectomy to exclude endometrial pathology: transvaginal ultrasound to assess endometrial thickness (greater than 4 mm in postmenopausal women warrants biopsy) and endometrial biopsy (Pipelle or hysteroscopic) are standard steps in the workup. Simple polypectomy in these women must not substitute for a thorough evaluation of endometrial pathology.

Simple twist-and-avulsion polypectomy — the most common outpatient technique — involves grasping the polyp with ring forceps and rotating until the stalk avulses. This is performed without anaesthesia in the outpatient clinic, is well-tolerated by most patients, and provides adequate histological specimen for pathological examination. It is successful for most small to medium pedunculated polyps with a narrow stalk.

For larger polyps, sessile polyps (broad-based without a narrow stalk), or those arising high in the endocervical canal and not easily accessible at the external os, polypectomy under hysteroscopic visualisation is preferred. Hysteroscopic polypectomy uses a fine telescope introduced into the uterine cavity under local cervical block or light sedation, providing direct visualisation for complete excision with cold scissors or a monopolar or bipolar resection loop. Hysteroscopic removal ensures complete excision of the stalk base, reducing recurrence rates, and simultaneously allows inspection of the uterine cavity for concurrent endometrial pathology. Cauterisation of the polypectomy base reduces bleeding and recurrence risk. Laser or diathermy excision is used at some centres. Endometrial sampling is performed simultaneously when polyps are associated with abnormal uterine bleeding to exclude concurrent endometrial pathology. For recurrent polyps, hysteroscopic polypectomy base treatment reduces bleeding and recurrence risk. Laser or diathermy excision is used at some centres. Hormonal management of underlying causes (anovulation, unopposed oestrogen) is addressed after polyp removal.

Polypectomy provides immediate relief of symptoms — post-coital bleeding, intermenstrual bleeding, and discharge resolve in the majority of patients after polyp removal. The procedure is virtually painless when small polyps are twisted off in the clinic, causes minimal disruption to daily activities, and provides histological confirmation of the benign nature of the growth in over 99% of cases. Achieving histological confirmation provides significant reassurance to the patient and allows clinical follow-up to be stratified appropriately.

For symptomatic cervical polyps causing menorrhagia or recurrent post-coital bleeding, polypectomy is curative in approximately 80–85% of cases. Recurrence of cervical polyps occurs in approximately 15–20% of patients over five years, particularly in those with ongoing oestrogenic stimulation (perimenopause), and may require repeat polypectomy. Hysteroscopic polypectomy with base cauterisation has lower recurrence rates than simple twist-and-avulsion.

Cervical polypectomy is a very low-risk procedure with minimal complications. Immediately after twist-and-avulsion polypectomy, mild spotting or light vaginal bleeding occurs in most patients and resolves within twenty-four to forty-eight hours. Significant haemorrhage requiring haemostasis occurs in below 1% of outpatient polypectomies; cauterisation or Monsel's solution (ferric subsulphate) controls this in the clinic. Cervical perforation — penetration of the cervical canal by instruments — is a rare complication of hysteroscopic procedures occurring in approximately 0.5% of cases; uterine perforation is rarer still. Vasovagal episodes — dizziness, sweating, and transient loss of consciousness in response to cervical manipulation — affect approximately 5% of patients during outpatient hysteroscopic procedures and are managed by stopping the procedure and patient positioning.

Incomplete removal of the polyp stalk — leaving behind the epithelial base — is the main risk of simple twist-and-avulsion, leading to polyp recurrence. Infection after polypectomy is uncommon but can present as fever, pelvic pain, or purulent discharge; prophylactic antibiotics are not routinely required for simple polypectomy. Rarely, polypectomy histology reveals unexpected malignancy or pre-malignant change, requiring further investigation and colposcopy with directed biopsy.

After simple outpatient polypectomy, patients can return to normal activities the same day. Mild spotting for one to three days is normal. Tampons and sexual intercourse are avoided for one week to allow healing. Shower bathing is preferred over bathing for the first week. Histology results are typically available within one to two weeks; normal or benign results require no further specific action. If histology reveals unexpected findings (CIN, adenocarcinoma in situ, or frankly malignant cells), urgent colposcopy and further investigation are arranged.

After hysteroscopic polypectomy, mild pelvic cramps and spotting for two to three days are typical. Activity restrictions and follow-up are similar to outpatient polypectomy. Women with postmenopausal bleeding have their endometrial evaluation results reviewed concurrently with polyp histology. Colposcopic surveillance of the cervix continues according to national cervical screening guidelines — polypectomy does not replace or substitute for cervical screening. Recurrent polyps detected on follow-up examination are managed by repeat polypectomy with histological examination.

Simple cervical polypectomy by twist-and-avulsion in the outpatient clinic is one of the least expensive gynaecological procedures. In the United States, an office-based polypectomy costs USD 500–1,500 including physician fees and pathology. Hysteroscopic polypectomy in a procedural suite costs USD 2,000–5,000. UK NHS provides polypectomy as part of routine gynaecological care; private polypectomy in the UK costs GBP 800–2,500. In India, cervical polypectomy is available at virtually all gynaecological clinics and hospitals for USD 100–500; hysteroscopic polypectomy for USD 300–1,000. These cost differences make India highly cost-effective for planned gynaecological procedures. Thailand charges USD 500–1,500; Turkey USD 400–1,000.

For most patients, cervical polypectomy is a straightforward procedure requiring no specific international travel planning. However, patients already in India, Thailand, or Turkey for other medical procedures can easily add a same-day hysteroscopic polypectomy to their treatment plan at marginal additional cost.

Expectant management — observing the polyp without removal — may be appropriate for very small asymptomatic polyps found incidentally in low-risk young women, with repeat examination in six to twelve months. However, the simplicity and safety of polypectomy and the importance of histological examination to exclude malignancy in the small minority of cases mean that removal is generally recommended for all accessible cervical polyps. There is no proven pharmacological treatment to cause polyp regression. Intrauterine contraceptive devices (IUDs) or progestin-releasing IUDs do not prevent cervical polyp formation. Colposcopy with directed cervical biopsy is performed when the polyp coexists with an abnormal cervical appearance on speculum examination to ensure no concurrent CIN or malignancy is present in the transformation zone.